Ozempic and Wegovy, Novo Nordisk’s Weight Loss Drugs, Reshape Denmark’s Economy


Novo Nordisk, the Danish company behind two popular obesity medications, is reaping huge profits and is now responsible for most of Denmark’s economic growth.

Previous Story

Tech Chiefs to Gather in Washington Next Month on A.I. Regulations

Next Story

U.S. and China Agree to Broaden Talks in Bid to Ease Tensions